BRISTOL-MYERS SQUIBB COMPANY Property, Plant and Equipment, Gross
BRISTOL-MYERS SQUIBB COMPANY (BMY) had Property, Plant and Equipment, Gross of $13.34 billion as of 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization › Property, Plant, and Equipment, before Accumulated Depreciation, Depletion, and Amortization
us-gaap:PropertyPlantAndEquipmentGross · last filed 2026-07-30
- 2026-06-30: Property, Plant and Equipment, Gross $13.34B.
- 2026-03-31: Property, Plant and Equipment, Gross $13.09B.
- 2025-12-31: Property, Plant and Equipment, Gross $12.84B.
- 2025-09-30: Property, Plant and Equipment, Gross $12.54B.
| Period end | Property, Plant and Equipment, Gross |
|---|---|
| 2026-06-30 | $13.34B 10-Q · filed 2026-07-30 |
| 2026-03-31 | $13.09B 10-Q · filed 2026-04-30 |
| 2025-12-31 | $12.84B 10-Q · filed 2026-07-30 |
| 2025-09-30 | $12.54B 10-Q · filed 2025-10-30 |
| 2025-06-30 | $12.68B 10-Q · filed 2025-07-31 |
| 2025-03-31 | $12.32B 10-Q · filed 2025-04-24 |
| 2024-12-31 | $12.09B 10-K · filed 2026-02-11 |
| 2024-09-30 | $11.74B 10-Q · filed 2024-10-31 |
| 2024-06-30 | $11.93B 10-Q · filed 2024-07-26 |
| 2024-03-31 | $11.69B 10-Q · filed 2024-04-25 |
| 2023-12-31 | $11.45B 10-K · filed 2025-02-12 |
| 2023-09-30 | $11.13B 10-Q · filed 2023-10-26 |
| 2023-06-30 | $10.83B 10-Q · filed 2023-07-27 |
| 2023-03-31 | $10.52B 10-Q · filed 2023-04-27 |
| 2022-12-31 | $10.42B 10-K · filed 2024-02-13 |
| 2022-09-30 | $10.17B 10-Q · filed 2022-10-26 |
| 2022-06-30 | $9.99B 10-Q · filed 2022-07-27 |
| 2022-03-31 | $10.21B 10-Q · filed 2022-04-29 |
| 2021-12-31 | $10.08B 10-K · filed 2023-02-14 |
| 2021-09-30 | $9.84B 10-Q · filed 2021-10-27 |
| 2021-06-30 | $9.63B 10-Q · filed 2021-07-28 |
| 2021-03-31 | $9.39B 10-Q · filed 2021-04-29 |
| 2020-12-31 | $9.47B 10-K · filed 2022-02-09 |
| 2020-09-30 | $9.41B 10-Q · filed 2020-11-05 |
| 2020-06-30 | $9.31B 10-Q · filed 2020-08-06 |
| 2020-03-31 | $9.55B 10-Q · filed 2020-05-07 |
| 2019-12-31 | $10.21B 10-K · filed 2021-02-10 |
| 2019-09-30 | $8.79B 10-Q · filed 2019-10-31 |
| 2019-06-30 | $8.69B 10-Q · filed 2019-07-25 |
| 2019-03-31 | $8.91B 10-Q · filed 2019-04-25 |
| 2018-12-31 | $8.85B 10-K · filed 2020-02-24 |
| 2018-09-30 | $9.18B 10-Q · filed 2018-10-25 |
| 2018-06-30 | $9.11B 10-Q · filed 2018-07-26 |
| 2018-03-31 | $9.16B 10-Q · filed 2018-04-26 |
| 2017-12-31 | $8.99B 10-K · filed 2019-02-25 |
| 2017-09-30 | $9.27B 10-Q · filed 2017-10-26 |
| 2017-06-30 | $9.12B 10-Q · filed 2017-07-27 |
| 2017-03-31 | $9.32B 10-Q · filed 2017-04-27 |
| 2016-12-31 | $9.17B 10-K · filed 2018-02-13 |
| 2016-09-30 | $8.93B 10-Q · filed 2016-10-27 |
| 2016-06-30 | $8.95B 10-Q · filed 2016-07-28 |
| 2016-03-31 | $8.76B 10-Q · filed 2016-04-28 |
| 2015-12-31 | $8.63B 10-K · filed 2017-02-21 |
| 2015-09-30 | $8.47B 10-Q · filed 2015-10-27 |
| 2015-06-30 | $9.15B 10-Q · filed 2015-07-23 |
| 2015-03-31 | $8.99B 10-Q · filed 2015-04-28 |
| 2014-12-31 | $9.07B 10-K · filed 2016-02-12 |
| 2014-09-30 | $8.96B 10-Q · filed 2014-10-24 |
| 2014-06-30 | $8.94B 10-Q · filed 2014-07-24 |
| 2014-03-31 | $8.86B 10-Q · filed 2014-04-29 |
| 2013-12-31 | $8.84B 10-K · filed 2015-02-13 |
| 2013-09-30 | $9.51B 10-Q · filed 2013-10-23 |
| 2013-06-30 | $9.39B 10-Q · filed 2013-07-25 |
| 2013-03-31 | $9.37B 10-Q · filed 2013-04-25 |
| 2012-12-31 | $9.38B 10-K · filed 2014-02-14 |
| 2012-09-30 | $9.28B 10-Q · filed 2012-10-24 |
| 2012-06-30 | $8.40B 10-Q · filed 2012-07-25 |
| 2012-03-31 | $8.45B 10-Q · filed 2012-04-26 |
| 2011-12-31 | $8.38B 10-K · filed 2013-02-15 |
| 2011-09-30 | $8.29B 10-Q · filed 2011-10-27 |
| 2011-06-30 | $8.34B 10-Q · filed 2011-07-28 |
| 2011-03-31 | $8.32B 10-Q · filed 2011-04-28 |
| 2010-12-31 | $8.26B 10-K · filed 2012-02-17 |
| 2010-09-30 | $8.29B 10-Q · filed 2010-10-26 |
| 2010-06-30 | $8.23B 10-Q · filed 2010-07-22 |
| 2009-12-31 | $8.89B 10-K · filed 2011-02-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |